1. Nanoparticle-mediated delivery of suicide genes in cancer therapy
   Riccardo Vago et al, 2016, Pharmacological Research CrossRef
2. Ligand-targeted particulate nanomedicines undergoing clinical evaluation: Current status
   Roy van der Meel et al, 2013, Advanced Drug Delivery Reviews CrossRef
3. Regulatory landscape in the approval of cancer vaccine
   Kamya Goyal et al, 2022, Nanotherapeutics in Cancer Vaccination and Challenges CrossRef
4. Nucleic acid-based drugs for patients with solid tumours
   Sebastian G. Huayamares et al, 2024, Nature Reviews Clinical Oncology CrossRef
5. Business models and opportunities for cancer vaccine developers
   Alex Kudrin, 2012, Human Vaccines & Immunotherapeutics CrossRef
6. Targeting Monoclonal Antibodies to the Tumor Microenvironment for Cancer Therapy/Immunotherapy
   null null et al, 2016, Journal of Immunology and Serum Biology CrossRef
7. Assessment of the Evolution of Cancer Treatment Therapies
   Manuel Arruebo et al, 2011, Cancers CrossRef
8. Drugs in clinical trials & future directions
   Zhiqiang Huang et al, 2011, Advances in Pancreatic Cancer Treatment CrossRef
9. Ligand-targeted Particulate Nanomedicines Undergoing Clinical Evaluation: Current Status
   Roy van der Meel et al, 2016, Intracellular Delivery III CrossRef
10. Our Journey Beyond Sunset Boulevard: Evidence-Based Analysis of Tumor-Targeted Cancer Gene Therapy Shines a Critical Spotlight on Long-Term Cancer-Free Survival
    Frederick L. Hall et al, 2021, Our Journey Beyond Sunset Boulevard - Evidence-based Analysis of Tumor-Targeted Gene- and Immuno-Therapies Shine a Critical Spotlight on “True” Long-Term Cancer-Free Survival CrossRef
11. Overview of cancer vaccines
    Alex Kudrin, 2012, Human Vaccines & Immunotherapeutics CrossRef